Prognostic importance of defibrillator shocks in patients with heart failure - Wikidata - wikimedia - TriplyDB

Prognostic importance of defibrillator shocks in patients with heart failure

Prognostic importance of defibrillator shocks in patients with heart failure

http://www.wikidata.org/entity/Q24631203

about

Ironic technology: Old age and the implantable cardioverter defibrillator in US health care Electrical storm: A clinical and electrophysiological overview European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review Home monitoring for heart failure management Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models Remote monitoring of patients with implanted cardiac devices.Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD)Surface Electrocardiogram Predictors of Sudden Cardiac Arrest Electrical Storm: Incidence, Prognosis and Therapy "Two for the Price of One": A Single-Lead Implantable Cardioverter-Defibrillator System with a Floating Atrial Dipole Ventricular arrhythmias in Chagas disease The subcutaneous ICD-current evidence and challenges A Questionable Indication For ICD Extraction After Successful VT Ablation 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Prophylactic implantable cardioverter defibrillator in heart failure: the growing evidence for all or Primum non nocere for some?Late Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy.Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death.Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques.Incidence, risk factors, and consequences of new-onset atrial fibrillation following epicardial ablation for ventricular tachycardia Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.Managing patients with advisory defibrillator leads: what can we learn from published data?Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry.Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary pr Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE Patient expectations from implantable defibrillators to prevent death in heart failure.Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®.Clinical relevance of slow ventricular tachycardia in heart failure patients with primary prophylactic implantable cardioverter defibrillator indication.Management of ventricular tachycardia in heart failure.Morphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: a multicenter study.Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.[Inappropriate ICD therapies: All problems solved with MADIT-RIT?].Evaluation of defibrillation safety and shock reduction in implantable cardioverter-defibrillator patients with increased time to detection: A randomized SANKS study.Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients.Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression.Carbon nanotube-incorporated collagen hydrogels improve cell alignment and the performance of cardiac constructs Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator.Influence of myopotential interference on the Wavelet discrimination algorithm in implantable cardioverter-defibrillator

P2860

Q24631162-03BE3AC9-307E-4183-9331-7F4D69577AC0 Q26785920-9C446CEB-A3D5-4F2B-BC61-561FAD923AE3 Q26796261-138C9A03-7A61-4D96-BA65-96C915CF9FC4 Q27006486-47C6D889-C86E-4FC7-B0D2-C7831793BDAE Q27023476-BD3072C3-47B6-47E6-97CF-E6963AF69BAF Q27318488-8D08DA86-1628-42A1-B9D3-9B88F3347873 Q27686906-1ADF86FB-6796-4137-90AC-5B86286BEB45 Q28067809-06E9A29E-C31D-4A76-9F53-55D63A01D543 Q28070357-0589B9E3-CAD2-408F-B42E-BC74809B25DB Q28075730-59DB4D86-1BF3-40F2-AEF1-B16D00DD0DD1 Q28078797-4C7B6DD7-C7E4-4800-9171-0A627F791656 Q28081429-9015A666-3E8B-4F23-825E-AE8A3EFAE9CD Q28081629-F02B55FF-09D7-489E-9456-1E0D386441B1 Q28082167-34613C67-07C4-449E-AD87-DD611E5A787A Q28087002-275E1602-DABA-40BA-AE0D-39A294343CA7 Q30235600-F0CC7830-5F86-4F30-BE89-4F0729D11949 Q30251600-CC69FBF5-030A-4FDC-BE65-DCB12A5F85E3 Q30418849-351F88CC-7B62-4B13-B95B-05C8B51A8C7F Q30419529-67BECD47-7D27-48F3-B6ED-BD82429000E8 Q30427599-3BCF3A38-A7F0-4F14-9968-7FF58D257AC3 Q30564158-172B762C-B3B2-4B76-972B-F8BE88DE9CCC Q30934904-FE267D5D-4C48-46AF-B834-F5A2AD869F6D Q31111661-7231C0DD-2A2A-4797-9429-8347A70F55DC Q31119225-2AEBAF2F-9E8C-43D6-A7F0-252FF1060DB0 Q33157547-9CFE29FD-E78E-41CB-A56F-E2F38782D6A9 Q33158266-5567A64D-196C-4817-A3F3-A80BFE65C6D7 Q33158361-B1FE6E90-5EF1-45F8-A9C2-293C8456A7BC Q33161388-7F8FB1D7-91DD-4AD9-8529-B319B5B002DF Q33162261-003CCA55-A4BB-4FCE-B393-69C3ED109A9B Q33162550-D36E5C71-BDC9-4628-81D2-F656DAB094E0 Q33163249-3CD6FE78-472B-4C80-905C-659D94AFB87A Q33163845-620D7E01-6C86-4417-9113-7AAE4B42EE84 Q33165644-E179087D-7179-4234-94D9-3127C394151C Q33166181-27AB31A0-A70F-4D97-918C-B739FE5EDF16 Q33166757-67845C8B-3CA1-4AE4-91A4-0D2662711555 Q33167254-49E7B05D-55BA-4E23-AD04-25BE4D819B87 Q33577173-3D83B7F6-2CAE-4E32-AAD6-00998DFEE85F Q33589396-563187BD-45D8-41C7-AF89-D10F1F7189B7 Q33644319-96D1D2CD-7104-46C1-8BEE-46B838901AE6 Q33764294-DED74F50-C1A7-44C6-B49F-EE0D2B15A693

P2860

Prognostic importance of defibrillator shocks in patients with heart failure

http://www.wikidata.org/entity/Q24631203

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Prognostic importance of defibrillator shocks in patients with heart failure

@ast

Prognostic importance of defibrillator shocks in patients with heart failure

@en

Prognostic importance of defibrillator shocks in patients with heart failure

@nl

type

label

Prognostic importance of defibrillator shocks in patients with heart failure

@ast

Prognostic importance of defibrillator shocks in patients with heart failure

@en

Prognostic importance of defibrillator shocks in patients with heart failure

@nl

prefLabel

Prognostic importance of defibrillator shocks in patients with heart failure

@ast

Prognostic importance of defibrillator shocks in patients with heart failure

@en

Prognostic importance of defibrillator shocks in patients with heart failure

@nl

P1433

Q24631203-7F3ED54D-862C-42EA-B37B-5AC3D4BCFCB8

P1476

Q24631203-AC7D81FE-F38F-436C-B320-6EB641D47C2C

P2093

Q24631203-09DF95F4-3D56-41F0-B61E-A19697511576

Q24631203-0D64EFD3-43E8-46C7-AF93-02A8698DA5AF

Q24631203-142D6FAE-C6C9-45FC-83C6-B18D6CB5AA15

Q24631203-4DA7CC99-11DE-4C8F-92B3-3F97A429F8EA

Q24631203-769059AF-E5B9-43DF-8D66-592E209C1396

Q24631203-AA7B09BA-118F-4CC1-A961-102A5C2451BD

Q24631203-E6D66D1E-A5D8-440C-9ABE-1571C49796A1

Q24631203-F60E4875-E0B3-4D3A-AC9C-C27B8B9FA98E

P2860

Q24631203-0CB2CD6F-8C0E-4F51-B83B-6851C75B5449

Q24631203-268FAEDD-8472-463F-A0A9-5E40ADFA80A7

Q24631203-35EBC786-D1D2-471C-A6AE-151E7315E13F

Q24631203-52FE9973-DF8A-4564-9EED-366555B97E7F

Q24631203-5BE5763F-EDDC-4DA6-9324-33A6166A6BA1

Q24631203-5EF96F81-9C63-4EA1-83C2-F10D8BF82906

Q24631203-789F9142-8C0B-460F-BB5A-1E5A98153AFA

Q24631203-87733A4E-6AC1-4FA3-ACC1-FAC1E3F50EA8

Q24631203-CADE1291-1368-44B2-8CBB-CD8EEA3F7517

Q24631203-E4191277-466A-4A24-8B72-DF802B99C862

P304

Q24631203-BFE96BFE-9FC0-471E-8919-1EDA375421EE

P31

Q24631203-3B7E05A4-8E47-4B50-BB25-5F7B0989F83F

P3181

Q24631203-629B3FEA-BC76-449A-A007-AA014898903A

P356

Q24631203-CFE7C247-898F-47DD-B55C-3C97EC33247F

P407

Q24631203-CBB12284-3F0E-4278-BDB1-2777C9494D3D

P433

Q24631203-8C8B863F-5ABC-4EC5-B77E-A653D74C34D6

P478

Q24631203-71646BF3-A36E-4C5E-AA2F-FE1B76BBD6E5

P50

Q24631203-04C6C5C0-2093-48DF-A0CC-C7C4B6F21F9D

Q24631203-3277228E-CEF7-45A6-ACE0-D23188B909F1

Q24631203-694F9E31-B0DE-4CAF-A67F-4277406975CE

Q24631203-9BCCF030-3580-4AF7-B247-5E18A4820286

Q24631203-BD858E40-1548-4C8E-9DC7-BF0A2E8DE7A8

Q24631203-BE00A833-65CC-4532-8206-63408F6F4D2A

Q24631203-D5934CE2-9EC6-4C4E-BC76-04421A342708

Q24631203-F0139723-2BB4-43EC-AA9C-CAC23B46D128

Q24631203-F402C942-706B-491C-8B3E-97D5C30D350C

P577

Q24631203-23BB7D95-7497-45FE-852D-BF7596FCDE92

P698

Q24631203-2220D120-D8EE-48C3-9EA0-9914D2EA0E0A

P921

Q24631203-517994CE-DB48-4268-B04B-DA49B957FAE7

Q24631203-58154400-568D-4105-87B7-5BFF57BA1CF7

P932

Q24631203-BDC3A63A-9EF1-4E46-A1AA-B4F6326CDC8A

P3181

P356

P1433

The New England Journal of Medicine

P1476

Prognostic importance of defibrillator shocks in patients with heart failure

@en

P2093

Daniel P Fishbein

http://www.w3.org/2001/XMLSchema#string

David J Callans

http://www.w3.org/2001/XMLSchema#string

David J Wilber

http://www.w3.org/2001/XMLSchema#string

Douglas L Packer

http://www.w3.org/2001/XMLSchema#string

George W Johnson

http://www.w3.org/2001/XMLSchema#string

Ramakota K Reddy

http://www.w3.org/2001/XMLSchema#string

Raymond Yee

http://www.w3.org/2001/XMLSchema#string

Thomas Guarnieri

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.

The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function.

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks.

Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.

Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.

P304

1009-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1756286

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA071098

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

359

http://www.w3.org/2001/XMLSchema#string

P50

Francis E. Marchlinski

Anne S Hellkamp

P577

2008-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18768944

http://www.w3.org/2001/XMLSchema#string

P921

P932

2922510

http://www.w3.org/2001/XMLSchema#string